EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rapid manufacturing of angiogenic cellular collagen patches for ischemic cardiomyopathy

Eric Pfrender, Sungwoo Kim, John A Farag, Shin Yajima, Yujiro Kawai, Koji Kawago, Umayr Syed, Gentaro Ikeda, Tsuyoshi Ueyama, Hiroyuki Takashima, Alex Dalal, Yuanjia Zhu iD und 9 weitere

Stem Cells Translational Medicine · 2025

DOI: 10.1093/stcltm/szaf035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells Translational Medicine, 2025. Verfasst von Eric Pfrender und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305, United States. Hauptthemen laut MEDLINE: Collagen, Neovascularization, Physiologic, Myocardial Ischemia, Endothelial Progenitor Cells. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, Department of Defense, Stanford Cardiovascular Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

One in ten Americans carry a lifetime risk of ischemic heart failure, the most severe form of ischemic heart disease. Carrying a nearly 50% five‑year mortality rate, no interventional therapy exists to treat the underlying cause, microvascular malperfusion. In efforts to combat microvascular malperfusion, our group has utilized synergistic application of endothelial progenitor cells (EPCs) and smooth muscle cells (SMCs) to induce angiogenesis in ischemic myocardium.

Methods

Cells are then embedded into a rapidly manufacturable compressed collagen (CC) patch to provide a biosimilar scaffold ready for transplantation. The performance of the cellular compressed collagen patch was then tested on a rodent acute myocardial infarction model of ischemic heart failure.

Results

By post‑transplantation Day 28, the cellular CC patch improved left ventricular ejection fraction when compared to an acellular CC patch and control (cellular: 49.1 ± 1.8%; acellular: 38.0 ± 2.6%; control: 39.2 ± 2.1%; ANOVA P = .0006). Cellular CC patch transplantation also induced mature angiogenesis as shown by arteriolar density (cellular: 1084 ± 98 αSMA+vWF+/mm2; acellular: 338 ± 57 αSMA+vWF+/mm2; control: 449 ± 39 αSMA+vWF+/mm2; ANOVA P = .0003) and vascular maturation index (cellular: 0.67 ± 0.04; acellular: 0.48 ± 0.02; and control: 0.46 ± 0.04, P = .001).

Conclusions

In conclusion, transplantation of a rapidly manufacturable EPC‑SMC‑based compressed collagen patch effectively rescues myocardial function by enhancing neovascularization and attenuating post‑infarction myocardial injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CollagenNeovascularization, PhysiologicMyocardial IschemiaEndothelial Progenitor CellsCardiomyopathiesAnimalsMaleRatsTissue ScaffoldsMyocytes, Smooth MuscleMyocardial InfarctionHumansDisease Models, Animal

Stichwörter der Autor:innen

angiogenesisbiomaterialscollagen patchendothelial progenitor cellsischemic cardiomyopathymyocardial infarctiontissue engineering

Substanzen

Collagen

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305, United States.
  • Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, United States.
  • Department of Orthopedic Surgery, Stanford University School of Medicine, Stanford, CA 94305, United States.
  • Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, United States.
  • Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States.
  • Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States.

ORCID-Profile: Yuanjia Zhu, Kenzo Ichimura, Y Joseph Woo, Yasuhiro Shudo

Förderung

  • NIAMS NIH HHS
  • Department of Defense
  • Stanford Cardiovascular Institute
  • NIH HHS
  • American Heart Association
  • Career Development
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Pfrender, E., Kim, S., Farag, J. A., Yajima, S., Kawai, Y., Kawago, K., Syed, U., Ikeda, G., Ueyama, T., Takashima, H., Dalal, A., Zhu, Y., Ichimura, K., Liu, Y., Moeinzadeh, S., Koltsov, J., Wu, J. C., Woo, Y. J., Yang, P. C., …, & Shudo, Y. (2025). Rapid manufacturing of angiogenic cellular collagen patches for ischemic cardiomyopathy. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szaf035

Vancouver

Pfrender E, Kim S, Farag JA, Yajima S, Kawai Y, Kawago K, et al. Rapid manufacturing of angiogenic cellular collagen patches for ischemic cardiomyopathy. Stem Cells Translational Medicine. 2025. doi:10.1093/stcltm/szaf035

BibTeX
@article{Pfrender2025,
  author = {Pfrender, Eric and Kim, Sungwoo and Farag, John A and Yajima, Shin and Kawai, Yujiro and Kawago, Koji and Syed, Umayr and Ikeda, Gentaro and Ueyama, Tsuyoshi and Takashima, Hiroyuki and Dalal, Alex and Zhu, Yuanjia and Ichimura, Kenzo and Liu, Yu and Moeinzadeh, Seyedsina and Koltsov, Jayme and Wu, Joseph C and Woo, Y Joseph and Yang, Phillip C and Yang, Yunzhi P and Shudo, Yasuhiro},
  title = {Rapid manufacturing of angiogenic cellular collagen patches for ischemic cardiomyopathy},
  journal = {Stem Cells Translational Medicine},
  year = {2025},
  doi = {10.1093/stcltm/szaf035}
}
Kostenlos starten →